The latest updates from AFAR.

Board Member in the News: CNN features Rudolph E. Tanzi, Ph.D. on the cost of Alzheimer's

Mar 20

Board Member in the News: CNN features Rudolph E. Tanzi, Ph.D. on the cost of Alzheimer's View MoreBACK

On March 7, 2017, CNN recently quoted Board Member and 1995 MetLife Foundation Awards for Medical Research in Alzheimer's Disease recipient Rudolph E. Tanzi, Ph.D., in its March 7 article on the distressing rate of Alzheimer's diease and its related costs. Dr. Tanzi, an expert in Alzheimer’s and other neurological diseases, offered his perspective on the impending financial impacts of Alzheimer’s.

The article describes how significant investment in research has created a decline in deaths from almost all major diseases in the U.S., except for Alzheimer's. Alzheimer's fatalities have doubled in the last 15 years, and by 2050, an American will develop Alzheimer’s every 33 seconds. Without greater investment in Alzheimer's research, it is unlikely scientists will be able to uncover how to modify, prevent, or cure Alzheimer's disease.

The article reports that lack of adequate funding in Alzheimer's research will also increase medical costs in treating Alzheimer's patients and the pressure it will put on social health care programs.

Dr. Tanzi explains, "Already, Alzheimer's consumes one in every five Medicare/Medicaid dollars. With 71 million baby boomers headed toward risk age, this will go to one in three, perhaps in the next decade, at which point Alzheimer's will single-handedly collapse Medicare/Medicaid."

Read the full article here.

Rudolph E. Tanzi, Ph.D. is the Director, Genetics and Aging Research Unit at MassGeneral Institute for Neurodegenerative Disease & Joseph P. and Rose F. Kennedy Professor of Neurology at Harvard Medical School.

For more on  Alzheimer’s disease , check out AFAR’s expert-edited InfoAging Center on Alzheimer's Disease.